Adicet Bio (ACET) has issued an announcement.
Adicet Bio, Inc. made a notable presentation at the 27th Annual Meeting of the American Society of Gene and Cell Therapy on May 10, 2024. The insightful details of their presentation, reflecting the latest developments, are now accessible for investors and the public on the company’s website. This move highlights Adicet Bio’s commitment to transparency and communication with stakeholders interested in the cutting-edge field of gene and cell therapy.
Learn more about ACET stock on TipRanks’ Stock Analysis page.
